Blue Ledge Capital
Blue Ledge Capital is a venture capital firm founded in 2020 and located in Larkspur, California. The firm focuses on investing in early-stage companies, providing them with the necessary capital and support to drive growth and innovation. Blue Ledge Capital aims to identify and partner with promising entrepreneurs and startups, fostering the development of new ideas and business models across various sectors. Its strategic approach combines financial investment with hands-on guidance, helping portfolio companies navigate challenges and achieve their objectives.
Top Stages
3 past transactions
Qnovia
Series B in 2024
Qnovia is a biotechnology company that specializes in aerosol science and drug delivery systems. It focuses on developing innovative inhalation-based technologies that enhance the delivery of a wide range of pharmaceuticals, addressing the limitations of traditional drug delivery methods. The company aims to improve patient outcomes by creating efficient aerosol devices and formulations that safely administer medications and nicotine. Qnovia is committed to advancing public health through responsible innovation, transparent product information, and effective oversight, positioning itself at the forefront of the medical device industry. Its platform not only optimizes the user experience but also facilitates access to new inhaled therapies, ultimately contributing to better health management for patients.
AvantGuard
Seed Round in 2023
AvantGuard creats innovative solutions that manage surfaces and provide long-term protection against viruses, bacteria, and fungi/mold, in a variety of applications.
Qnovia
Series A in 2022
Qnovia is a biotechnology company that specializes in aerosol science and drug delivery systems. It focuses on developing innovative inhalation-based technologies that enhance the delivery of a wide range of pharmaceuticals, addressing the limitations of traditional drug delivery methods. The company aims to improve patient outcomes by creating efficient aerosol devices and formulations that safely administer medications and nicotine. Qnovia is committed to advancing public health through responsible innovation, transparent product information, and effective oversight, positioning itself at the forefront of the medical device industry. Its platform not only optimizes the user experience but also facilitates access to new inhaled therapies, ultimately contributing to better health management for patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.